These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20720435

  • 1. CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis.
    Szczuciński A, Losy J.
    Neuroimmunomodulation; 2011; 18(1):67-72. PubMed ID: 20720435
    [Abstract] [Full Text] [Related]

  • 2. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA, Tilbery CP, Monteiro LP, Teixeira MM, Teixeira AL.
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [Abstract] [Full Text] [Related]

  • 3. CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone.
    Szczuciński A, Kalinowska A, Losy J.
    Eur Neurol; 2007 Aug; 58(4):228-32. PubMed ID: 17827967
    [Abstract] [Full Text] [Related]

  • 4. Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients.
    Kalinowska-Łyszczarz A, Szczuciński A, Pawlak MA, Losy J.
    J Neurol Sci; 2011 Jan 15; 300(1-2):81-5. PubMed ID: 20947098
    [Abstract] [Full Text] [Related]

  • 5. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
    Bartosik-Psujek H, Stelmasiak Z.
    Eur Neurol; 2004 Jan 15; 52(4):237-41. PubMed ID: 15550762
    [Abstract] [Full Text] [Related]

  • 6. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
    Teleshova N, Pashenkov M, Huang YM, Söderström M, Kivisäkk P, Kostulas V, Haglund M, Link H.
    J Neurol; 2002 Jun 15; 249(6):723-9. PubMed ID: 12111306
    [Abstract] [Full Text] [Related]

  • 7. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid.
    Mellergård J, Edström M, Vrethem M, Ernerudh J, Dahle C.
    Mult Scler; 2010 Feb 15; 16(2):208-17. PubMed ID: 20007431
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
    Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Dobosz B, Stelmasiak Z.
    Acta Neurol Scand; 2004 Jun 15; 109(6):390-2. PubMed ID: 15147461
    [Abstract] [Full Text] [Related]

  • 9. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P, Losy J, Kramer L, Wójcicka M, Kaufman E.
    J Neurol Sci; 2017 Sep 15; 380():22-26. PubMed ID: 28870573
    [Abstract] [Full Text] [Related]

  • 10. Concentration gradient of CXCL10 and CXCL11 between the cerebrospinal fluid and plasma in children with enteroviral aseptic meningitis.
    Cavčić A, Tešović G, Gorenec L, Grgić I, Benić B, Lepej SŽ.
    Eur J Paediatr Neurol; 2011 Nov 15; 15(6):502-7. PubMed ID: 21703889
    [Abstract] [Full Text] [Related]

  • 11. The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis.
    Jalosinski M, Karolczak K, Mazurek A, Glabinski A.
    Acta Neurol Scand; 2008 Aug 15; 118(2):120-5. PubMed ID: 18336625
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
    Zajkowska J, Moniuszko-Malinowska A, Pancewicz SA, Muszyńska-Mazur A, Kondrusik M, Grygorczuk S, Swierzbińska-Pijanowska R, Dunaj J, Czupryna P.
    Adv Med Sci; 2011 Aug 15; 56(2):311-7. PubMed ID: 22008312
    [Abstract] [Full Text] [Related]

  • 13. Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick-borne encephalitis.
    Lepej SZ, Misić-Majerus L, Jeren T, Rode OD, Remenar A, Sporec V, Vince A.
    Acta Neurol Scand; 2007 Feb 15; 115(2):109-14. PubMed ID: 17212614
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11.
    Lepej SZ, Rode OD, Jeren T, Vince A, Remenar A, Barsić B.
    J Neuroimmunol; 2005 Jun 15; 163(1-2):128-34. PubMed ID: 15885315
    [Abstract] [Full Text] [Related]

  • 15. The impact of multiple sclerosis relapse treatment on migration of effector T cells--Preliminary study.
    Jatczak-Pawlik I, Książek-Winiarek D, Wojkowska D, Jóźwiak K, Jastrzębski K, Pietruczuk M, Głąbiński A.
    Neurol Neurochir Pol; 2016 Jun 15; 50(3):155-62. PubMed ID: 27154441
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of serum levels of chemokines during interferon-β treatment in multiple sclerosis patients: a 1-year, observational cohort study.
    Comini-Frota ER, Teixeira AL, Angelo JP, Andrade MV, Brum DG, Kaimen-Maciel DR, Foss NT, Donadi EA.
    CNS Drugs; 2011 Nov 01; 25(11):971-81. PubMed ID: 22054120
    [Abstract] [Full Text] [Related]

  • 17. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
    Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F.
    Scand J Immunol; 2006 Aug 01; 64(2):155-63. PubMed ID: 16867161
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
    Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer B.
    Arch Neurol; 2009 Oct 01; 66(10):1216-23. PubMed ID: 19667211
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
    Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM.
    Arthritis Rheum; 2009 Nov 01; 60(11):3436-46. PubMed ID: 19877033
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes.
    Fischer HJ, Finck TLK, Pellkofer HL, Reichardt HM, Lühder F.
    Front Immunol; 2019 Nov 01; 10():1200. PubMed ID: 31191554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.